Russell Investments Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9K | Sell |
6,229
-471
| -7% | -$3.02K | ﹤0.01% | 3035 |
|
|
2025
Q1 | $23.7K | Buy |
6,700
+1,631
| +32% | +$5.77K | ﹤0.01% | 3071 |
|
|
2024
Q4 | $19.2K | Sell |
5,069
-1,920
| -27% | -$7.26K | ﹤0.01% | 3015 |
|
|
2024
Q3 | $22.6K | Sell |
6,989
-2,130
| -23% | -$6.9K | ﹤0.01% | 2934 |
|
|
2024
Q2 | $17.3K | Buy |
9,119
+8,957
| +5,529% | +$17K | ﹤0.01% | 2967 |
|
|
2024
Q1 | $460 | Sell |
162
-2,675
| -94% | -$7.6K | ﹤0.01% | 3216 |
|
|
2023
Q4 | $41.8K | Sell |
2,837
-1,646
| -37% | -$24.2K | ﹤0.01% | 2653 |
|
|
2023
Q3 | $82.1K | Buy |
4,483
+4,289
| +2,211% | +$78.5K | ﹤0.01% | 2661 |
|
|
2023
Q2 | $4.19K | Buy |
194
+162
| +506% | +$3.5K | ﹤0.01% | 3143 |
|
|
2023
Q1 | $939 | Buy |
+32
| New | +$939 | ﹤0.01% | 3052 |
|